These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 22879951

  • 1. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
    Wu CY, Yeh YC, Chan JT, Yang YC, Yang JR, Liu MT, Wu HS, Hsiao PW.
    PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
    [Abstract] [Full Text] [Related]

  • 2. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L, Kays SK, Zimmer G, von Messling V.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925654
    [Abstract] [Full Text] [Related]

  • 3. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ, Gabbard JD, Li Z, Dlugolenski DA, Johnson SK, Tripp RA, He B, Tompkins SM.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931689
    [Abstract] [Full Text] [Related]

  • 4. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
    Skarlupka AL, Bebin-Blackwell AG, Sumner SF, Ross TM.
    J Virol; 2021 Aug 10; 95(17):e0075921. PubMed ID: 34160258
    [Abstract] [Full Text] [Related]

  • 5. Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection.
    Kang HJ, Chu KB, Yoon KW, Eom GD, Mao J, Kim MJ, Lee SH, Moon EK, Quan FS.
    Viruses; 2022 Feb 18; 14(2):. PubMed ID: 35216022
    [Abstract] [Full Text] [Related]

  • 6. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM, Darby CA, Johnson SK, Carlock MA, Kirchenbaum GA, Allen JD, Vogel TU, Delagrave S, DiNapoli J, Kleanthous H, Ross TM.
    J Virol; 2017 Dec 15; 91(24):. PubMed ID: 28978709
    [Abstract] [Full Text] [Related]

  • 7. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
    Tao P, Luo M, Zhu D, Qu S, Yang Z, Gao M, Guo D, Pan Z.
    Viral Immunol; 2009 Jul 15; 22(4):273-81. PubMed ID: 19594398
    [Abstract] [Full Text] [Related]

  • 8. Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.
    Carter DM, Darby CA, Lefoley BC, Crevar CJ, Alefantis T, Oomen R, Anderson SF, Strugnell T, Cortés-Garcia G, Vogel TU, Parrington M, Kleanthous H, Ross TM.
    J Virol; 2016 May 15; 90(9):4720-4734. PubMed ID: 26912624
    [Abstract] [Full Text] [Related]

  • 9. Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.
    Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, Wu Y, Kpamegan E, Courbron D, Fries LF, Glenn GM.
    Vaccine; 2013 Sep 13; 31(40):4305-13. PubMed ID: 23891795
    [Abstract] [Full Text] [Related]

  • 10. Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans.
    Rijal P, Wang BB, Tan TK, Schimanski L, Janesch P, Dong T, McCauley JW, Daniels RS, Townsend AR, Huang KA.
    J Virol; 2020 Jan 31; 94(4):. PubMed ID: 31748388
    [Abstract] [Full Text] [Related]

  • 11. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V, Chiang C, Kirchenbaum GA, Olagnier D, Bloom CE, Wong T, Haddad EK, Trautmann L, Ross TM, Hiscott J.
    J Virol; 2015 Oct 31; 89(20):10612-24. PubMed ID: 26269188
    [Abstract] [Full Text] [Related]

  • 12. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y, Boltz D, Sarawar S, Kawaoka Y, Neumann G, Bilsel P.
    Vaccine; 2017 Jul 24; 35(33):4177-4183. PubMed ID: 28668565
    [Abstract] [Full Text] [Related]

  • 13. Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus.
    Lee GJ, Chu KB, Inn KS, Moon EK, Quan FS.
    Immunol Invest; 2020 Oct 24; 49(7):781-793. PubMed ID: 31774021
    [Abstract] [Full Text] [Related]

  • 14. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    Tian X, Landreth S, Lu Y, Pandey K, Zhou Y.
    J Virol; 2021 Jan 13; 95(3):. PubMed ID: 33177192
    [Abstract] [Full Text] [Related]

  • 15. Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine.
    Nakayama M, Shichinohe S, Itoh Y, Ishigaki H, Kitano M, Arikata M, Pham VL, Ishida H, Kitagawa N, Okamatsu M, Sakoda Y, Ichikawa T, Tsuchiya H, Nakamura S, Le QM, Ito M, Kawaoka Y, Kida H, Ogasawara K.
    PLoS One; 2013 Jan 13; 8(12):e82740. PubMed ID: 24376571
    [Abstract] [Full Text] [Related]

  • 16. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W, Wang S, Chen H, Ren H, Huang X, Wang G, Chen Z, Chen L, Chen Z, Zhou P.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28179535
    [Abstract] [Full Text] [Related]

  • 17. Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.
    Ding H, Tsai C, Zhou F, Buchy P, Deubel V, Zhou P.
    PLoS One; 2011 Mar 25; 6(3):e17821. PubMed ID: 21464977
    [Abstract] [Full Text] [Related]

  • 18. Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses.
    Mytle N, Leyrer S, Inglefield JR, Harris AM, Hickey TE, Minang J, Lu H, Ma Z, Andersen H, Grubaugh ND, Guina T, Skiadopoulos MH, Lacy MJ.
    Viruses; 2021 Aug 27; 13(9):. PubMed ID: 34578289
    [Abstract] [Full Text] [Related]

  • 19. Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.
    Brewoo JN, Powell TD, Jones JC, Gundlach NA, Young GR, Chu H, Das SC, Partidos CD, Stinchcomb DT, Osorio JE.
    Vaccine; 2013 Apr 03; 31(14):1848-55. PubMed ID: 23376279
    [Abstract] [Full Text] [Related]

  • 20. A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection.
    Giles BM, Crevar CJ, Carter DM, Bissel SJ, Schultz-Cherry S, Wiley CA, Ross TM.
    J Infect Dis; 2012 May 15; 205(10):1562-70. PubMed ID: 22448011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.